Fierce Pharma

MARCH 24, 2023

Sanofi, Regeneron's Dupixent could hit $20B in peak sales with COPD expansion: analyst kdunleavy Fri, 03/24/2023 - 07:30

Sales 254

Sales 254

MedCity News

MARCH 24, 2023

Check out news from OUI Medical, Vital, Cognito Therapeutics and Reveal HealthTech.

Healthcare 123

Healthcare Healthcare Medical 123

Fierce Pharma

MARCH 24, 2023

GSK plays defense after California judge approves plaintiff's expert testimony in high-stakes Zantac trial fkansteiner Fri, 03/24/2023 - 10:05

228

228

MedCity News

MARCH 24, 2023

These are challenging times for health care, and particularly for women in health care.

122

122

Advertiser: ZoomInfo

Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.

Sales

Fierce Pharma

MARCH 24, 2023

Brii Bio shelves once-promising COVID antibody combo that stood up to variants kdunleavy Fri, 03/24/2023 - 10:07

199

199

PM360

MARCH 24, 2023

Technology evolves fast. Nothing illustrates that better than attending SXSW each year and noticing how much has changed in just 12 months. In 2022, SXSW was all NFTs and metaverse activations and events, and in 2023 they weren’t anywhere to be found. But a lot was shared at this year’s SXSW that had staying power. In place of NFTs, psychedelics were given their own conference track this year.

Media 119

Media Engineering Healthcare Healthcare 119

MedCity News

MARCH 24, 2023

Flare Therapeutics, EpiBiologics, and Mbiomics are among the biotech companies that recently unveiled new rounds of financing.

Biopharma 110

Biopharma Pharma 110

Fierce Pharma

MARCH 24, 2023

With rejection for slow-release Jakafi, FDA sends shockwaves across Incyte's pipeline: analyst aliu Fri, 03/24/2023 - 10:04

FDA 147

FDA 147

MedCity News

MARCH 24, 2023

Oak Street Health teamed up with kidney care management company Interwell Health to create a joint venture called OakWell, which seeks to provide primary care to end-stage kidney disease patients directly in existing dialysis centers. End stage kidney disease patients spend upwards of 12 hours per week in dialysis centers — OakWell is meant to eliminate the barrier of attending separate, additional medical appointments.

Management 109

Management Medical Patients 109

European Pharmaceutical Review

MARCH 24, 2023

Following the recent announcement of topline results from 89bio’s Phase IIb trial, ENLIVEN, evaluating FGF21 analogue pegozafermin for nonalcoholic steatohepatitis (NASH), a serious liver condition, EPR spoke with Dr Hank Mansbach, the company’s Chief Medical Officer. NASH currently has no approved treatments. Caused by excess fat, it is referred to as the ‘silent killer’, as most affected individuals don’t exhibit symptoms until liver damage has already occurred.

Medical 108

Medical Side effects Pharmaceutical Patients 108

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Copyright Clearance Center

MARCH 24, 2023

The post At London Book Fair, Spotlight on Ukraine appeared first on Copyright Clearance Center.

98

98

PM360

MARCH 24, 2023

Cancer-support programs provide vital assistance to patients and their caregivers as they face one of the toughest times of their lives. Yet while patients are interested in these programs, new survey data suggests they aren’t taking advantage of them. Results from 825 patients diagnosed with or treated for cancer who were surveyed on Phreesia’s PatientInsights platform as they checked in for their doctors’ appointments revealed that few cancer patients are accessing the support resources availa

Patients 98

Patients Education Side effects Media 98

PharmaVoice

MARCH 24, 2023

How life science execs would transform clinical trials with a little hocus pocus.

Pharma 98

Pharma 98

European Pharmaceutical Review

MARCH 24, 2023

AstraZeneca has announced the first and only dual-combination inhaled corticosteroid and long-acting beta2-agonist (ICS/LABA) treatment for mild asthma has been approved in the UK. The marketing authorisation has been given to budesonide/formoterol (Symbicort Turbohaler 200/6) as a reliever therapy for patients over 12 years old. The combination therapy, delivered as a formulation in a single inhaler contains b udesonide, an inhaled corticosteroid (ICS) and f ormoterol, a long-acting beta2-agoni

Medicine 97

Medicine Patients Healthcare Healthcare 97

Advertiser: ZoomInfo

In today’s ultra-competitive markets, it’s no longer enough to wait for buyers to show obvious signs of interest. Instead, sales teams must be proactive, identifying and acting on nuanced buyer behaviors — often before prospects are fully ready to make a purchase. In this eBook from ZoomInfo & Sell Better, learn 10 actionable ways to use these buyer signals to transform your sales strategy and close deals faster.

Sales Strategy

PM360

MARCH 24, 2023

Unacknowledged personal biases in the workplace can quickly spiral, leaving employees feeling alienated and disengaged. This has far-reaching implications that can also influence external brand experiences with target stakeholders. In the healthcare industry, this is especially concerning as it can contribute to health disparities and impact progress toward health equity : better health and well-being for all.

Healthcare 96

Healthcare Healthcare Education Leads 96

European Pharmaceutical Review

MARCH 24, 2023

The European Medicines Agency (EMA) has published a report summarising the mid-point achievements of its Regulatory Science Strategy (RSS) to 2025. Initially published in March 2020, the strategy provides a plan for advancing regulatory science over a five-year period. Regulatory science refers to the scientific disciplines that are applied to the quality, safety and efficacy assessment of medicinal products.

Medicine 96

Medicine Consulting Networking Safety 96

PM360

MARCH 24, 2023

Drug price transparency (DPT) laws have been in effect in several states for a few years now. Starting with Vermont in 2016, more than half of the U.S. states are now collecting pricing data from manufacturers in the hopes it will assist in creating effective policies to reduce drug prices for their constituents. The question of whether this goal will be realized or not remains unanswered for now.

Manufacturing 96

Manufacturing Retail Management Marketing 96

Pharmaceutical Commerce

MARCH 24, 2023

Pharma Commerce offers a synopsis of some of the conference’s events.

Pharma 96

Pharma 96

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

PM360

MARCH 24, 2023

Let’s talk digital transformation! In January, I started my series by identifying five key components of a successful digital transformation. We covered the first one by looking at Organizational Structures , today, let’s dive into the second which is the toughest, not just for pharma, but for the entire country: Diversity, Equity, and Inclusion (DE&I).

Pharma 94

Pharma Education Digital Media Media 94

PharmaTimes

MARCH 24, 2023

Study shows significant reduction of nasal S.

Patients 92

Patients 92

PM360

MARCH 24, 2023

Pharma marketers often turn to disease awareness days, weeks, and months to inform campaigns as they strategize for the year ahead. With the sheer number of official awareness days out there, it’s no wonder they’ve become a pillar to a marketer’s early plan development. To the pharma marketing industry, these days and months present a clear opportunity to shed light on a particular condition or therapeutic area.

Media 92

Media Education Pharma Networking 92

PharmaTimes

MARCH 24, 2023

21GRAMS takes four Golds plus Best in Show AstraZeneca tops the pharma leader board

Pharma 88

Pharma 88

Advertiser: ZoomInfo

As prospects define their problem, search for solutions, and even change jobs, they are generating high-value signals that the best go-to-market teams can leverage to close more deals. This is where signal-based selling comes into play. ZoomInfo CEO Henry Schuck recently broke down specific ways to put four key buying signals into action with the experts from 30 Minutes to President’s Club.

Prospecting

Pharmaceutical Technology

MARCH 24, 2023

Biosimilars for AbbVie’s (US) Humira (adalimumab) have finally launched in the US, bringing an end to Humira’s 20-year reign as the best-selling biologic of all time. Biosimilars are an important tool to facilitate competition, lower the price of drugs, and create savings across the board. Amgen’s (US) Amjevita (adalimumab) is the first Humira biosimilar, launched in February 2023, and seven other FDA-approved biosimilars are expected to arrive on the US market later this year.

Competition 59

Competition Marketing FDA Physicians 59

PharmaTimes

MARCH 24, 2023

The multi-centre international clinical trial will evaluate company’s Debio 0328 candidate

71

71

Medico Reach

MARCH 24, 2023

The American Cancer Society estimates 1,958,310 new cases of cancer in the United States in 2023. As a result, a global approach to healthcare has emerged continually over the years. Even for cancers that are difficult to treat, new treatments and technologies improve patient survival rates. Hence, new oncology market trends will set in as doctors and pharmaceutical companies work towards individualized treatment decisions.

Marketing 52

Marketing Medicine Healthcare Healthcare 52

PharmExec

MARCH 24, 2023

The partnership was sealed to support U.S. launch & commercialization of a medical device to help cancer patients manage and treat oral mucositis.

Management 52

Management Medical Patients 52

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

Medico Reach

MARCH 24, 2023

The American Cancer Society estimates 1,958,310 new cases of cancer in the United States in 2023. As a result, a global approach to healthcare has emerged continually over the years. Even for cancers that are difficult to treat, new treatments and technologies improve patient survival rates. Hence, new oncology market trends will set in as doctors and pharmaceutical companies work towards individualized treatment decisions.

Marketing 52

Marketing Medicine Healthcare Healthcare 52

PharmaTech

MARCH 24, 2023

A new Interagency Working Group for Bayh-Dole will review the government’s authority to revoke licenses for medical products.

Medical 52

Medical 52

PharmExec

MARCH 24, 2023

Amid continued tussling over drug costs, a new working group will review the government’s authority to revoke licenses for medical products.

Medical 52

Medical 52

PharmaTech

MARCH 24, 2023

Curia is collaborating with Corning to advance biopharmaceutical continuous-flow development and manufacturing programs.

Manufacturing 52

Manufacturing 52

Advertiser: ZoomInfo

Sales and marketing leaders have reached a tipping point when it comes to using intent data — and they’re not looking back. More than half of all B2B marketers are already using intent data to increase sales, and Gartner predicts this figure will grow to 70 percent. The reason is clear: intent can provide you with massive amounts of data that reveal sales opportunities earlier than ever before.

Sales